Antibody neutralization to SARS-CoV-2 and variants after 1 year in Wuhan, China

Most COVID-19 convalescents can build effective anti-SARS-CoV-2 humoral immunity, but it remains unclear how long it can maintain and how efficiently it can prevent the reinfection of the emerging SARS-CoV-2 variants. Here, we tested the sera from 248 COVID-19 convalescents around 1 year post-infect...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qianyun, Xiong, Qing, Mei, Fanghua, Ma, Chengbao, Zhang, Zhen, Hu, Bing, Xu, Junqiang, Jiang, Yongzhong, Zhan, Faxian, Zhou, Suhua, Tao, Li, Chen, Xianying, Guo, Ming, Wang, Xin, Fang, Yaohui, Shen, Shu, Liu, Yingle, Liu, Fang, Zhou, Li, Xu, Ke, Ke, Changwen, Deng, Fei, Cai, Kun, Yan, Huan, Chen, Yu, Lan, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563080/
https://www.ncbi.nlm.nih.gov/pubmed/34746904
http://dx.doi.org/10.1016/j.xinn.2021.100181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563080/
https://www.ncbi.nlm.nih.gov/pubmed/34746904
http://dx.doi.org/10.1016/j.xinn.2021.100181

Ejemplares similares